Am J Transplant, Volume 20, Suppl 3 Archives - Page 103 of 223 - ATC Abstracts

2020 American Transplant Congress
Evaluation of Rejection, Infection, and Malignancy Outcomes in Elderly Liver Transplant Recipients Compared to a Younger Cohort
B. Almalki¹, K. Cunningham¹, C. D'Agostino¹, M. Kapugi¹, C. Kane¹, A. Novak¹, D. Ladner², J. Schulte¹
¹Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, ²Division of Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Previous data has shown elderly liver transplant recipients (LTx) to be at a lower risk of acute rejection than younger recipients. As such, elderly…
2020 American Transplant Congress
Outcomes Following Deceased Donor Split/Partial Liver Transplant for Hepatocellular Carcinoma
L. Matsuoka, T. Sutcliffe, I. Feurer, S. Rega, S. Alexopoulos
Vanderbilt University Medical Center, Nashville, TN
*Purpose: To mitigate waiting time for liver transplant for hepatocellular carcinoma (HCC) and increase available organs, partial or split liver transplant (SLT) has been utilized.…
2020 American Transplant Congress
A Three-Decade Analysis of Pancreatic Adenocarcinoma Following Liver Transplantation
O. Y. Mousa¹, J. E. Corral², K. Wijarnpreecha², R. Shah³, V. S. Louwagie⁴, M. J. Bartel⁵, B. Brahmbhatt²
¹Mayo Clinic, Rochester, MN, ²Mayo Clinic, Jacksonville, FL, ³Emory University, Atlanta, GA, ⁴Mayo Clinic Health System, Mankato, MN, ⁵Fox Chase Cancer Center, Philadelphia, PA
*Purpose: Liver transplant (LT) recipients are at risk of serious long term complications, including a higher risk of de novo malignancies compared to the general…
2020 American Transplant Congress
Lack of Drug-Drug Interaction between Maribavir and Voriconazole
I. H. Song¹, K. Ilic², J. Wu³
¹Quantitative Clinical Pharmacology, Shire, a Takeda Company, Lexington, MA, ²Rare Disease TAU, Shire, a Takeda Company, Lexington, MA, ³Biostat, Shire, a Takeda Company, Lexington, MA
*Purpose: Maribavir is being evaluated in Phase 3 trials for the treatment of cytomegalovirus infections in transplant recipients. These patients often take numerous concomitant medications,…
2020 American Transplant Congress
Safety and Efficacy of Prophylactic Valganciclovir Dosing after Solid Organ Transplant
K. Gandhi, D. Masic, M. Santarossa, F. Albarillo, N. Clark, G. Reid
Loyola University Medical Center, Maywood, IL
*Purpose: At centers where antiviral prophylaxis is used after solid organ transplant, valganciclovir is administered for the prevention of cytomegalovirus (CMV). At Loyola University Medical…
2020 American Transplant Congress
Contract a Virus to Save a Life: A Comparison of Short Term Outcomes between Adult Hepatitis C Negative Kidney Transplant Recipients Receiving a Hepatitis C NAT Positive versus Hepatitis C Negative Deceased Donor Kidney
H. Schaefer¹, B. Concepcion¹, A. Sudhakar², S. Rega¹, I. Feurer¹, S. Shawar¹, B. Dubrey¹, D. Shaffer¹, R. Forbes¹
¹Vanderbilt University, Nashville, TN, ²Drexel University, Philadelphia, PA
*Purpose: The United States opioid use epidemic over the past decade has coincided with an increase in hepatitis C positive (HCV+) kidney donors. Our aim…
2020 American Transplant Congress
Analysis of Pre-Transplant Resuscitation Factors Influencing Immediate Graft Function after Deceased Donor Kidney Transplantation
S. Park
General Surgery, Seoul St. Mary's Hospital, Seoul, Korea, Republic of
*Purpose: The management of a deceased donor in the intensive care unit before organ transplantation is important for the outcome of the recipient. Herein, we…
2020 American Transplant Congress
Reduction in Physician Burnout among Transplant Surgeons: A Preliminary Result of the Role of ‘Medical Missions’
N. T. Ngo¹, D. Halpin², P. Sindhwani³, O. Ekwenna³
¹MS2, University of Toledo College of Medicine & Life Sciences, Toledo, OH, ²MS4, University of Toledo College of Medicine & Life Sciences, Toledo, OH, ³Department of Urology and Transplantation, University of Toledo College of Medicine & Life Sciences, Toledo, OH
*Purpose: The objective of this preliminary study was to report prevalence of burnout among transplant surgeons who participated in a cross-sectional survey and to assess…
2020 American Transplant Congress
Old World Monkeys Are Not Ideal Transplantation Models for Testing CMAHKO (TKO or GTKO/CMAHKO) Pig Kidneys
T. Yamamoto¹, H. Iwase¹, D. Patel¹, A. Jagdale¹, J. Foote¹, D. Ayares², D. Anderson¹, D. E. Eckhoff¹, D. K. Cooper¹, H. Hara¹
¹University of Alabama at Birmingham, Birmingham, AL, ²Revivicor, Blacksburg, VA
*Purpose: Triple-knockout (TKO) pigs are likely to be an optimal source of organs for transplantation into human recipients, many of whom do not have natural…
2020 American Transplant Congress
Influence of Human Leukocyte Antigen Status and Gender of Positive Crossmatch Patients on Long-Term Survival Outcomes of Antibody Incompatible Renal Transplantation
N. R. Macha¹, A. Abimbola¹, N. Khovanova², D. Briggs³, N. Krishnan⁴
¹CIRAL, Coventry University, Coventry, United Kingdom, ²School of Engineering, University of Warwick, Warwickshire, United Kingdom, ³Director, Tissue Typing Lab, NHSBT, Birmingham, United Kingdom, ⁴Consultant Transplant Nephrologist and Visiting Professor, CIRAL, University Hospital Coventry & Warwickshire, Coventry, United Kingdom
*Purpose: Human Leukocyte Antigen (HLA) sensitization is a significant obstacle which limits the use of renal transplantation, but it serves as a therapeutic option for…